Dotz Nano: Carbon Capture & Anti-Counterfeiting
The pilot succeeded. Then it sat in procurement, and the next pilot started somewhere else.
A diligence scaffold for two proof-heavy markets — anti-counterfeiting and carbon capture — where procurement, not narrative, decides the outcome.
What this is
A diligence scaffold framed around two markets — anti-counterfeiting and traceability, and carbon capture — rather than a company profile. Both are high-need categories with long enterprise sales cycles, where the outcome is decided by proof, integration friction, procurement and unit economics.
This is a framework for the category, not company-specific analysis. No Dotz Nano product, financial, customer or technology detail is presented here.
Why these two are hard
- Counterfeiting is costly, so brands and governments genuinely care about verification and traceability. Caring is not the same as buying.
- Carbon capture is judged on measured performance and cost per ton. Stories do not clear that bar.
- Adoption in both is procurement-driven: pilots, integration and measurable outcomes decide whether anything scales.
Four diligence lenses
- Buyer path: who pays, and what triggers procurement?
- Proof: pilots, repeat customers, and measured performance where it is verifiable.
- Integration: how much friction to deploy into a real workflow?
- Economics: cost structure, margins, and the ongoing support burden after the sale.
Named risks
- Long enterprise sales cycles, and pilot fatigue on the buyer side.
- Proof requirements that are expensive to generate.
- Competition from incumbents and from alternative approaches.
- One question resolves most of it: what proof exists that a buyer will pay at scale, and what does deployment actually cost?
Disclosure
GigHz holds a personal position or exposure in this company. That is disclosed here because you should weigh it.
Informational only. Not an offer to sell securities or a solicitation to buy, and not financial, medical, legal or tax advice. Past performance does not guarantee future results.
Informational only. Not investment, medical, legal, or tax advice. GigHz or its founder may hold a position in the company discussed — see the disclosure above.
Related from GigHz
Written and reviewed by Pouyan Golshani, MD, Interventional Radiologist — Last updated June 12, 2026
Part of the GigHz library: systems doctors were never taught.